𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology

✍ Scribed by Bessell, E.M.; Coutts, A.; Fletcher, J.; Toghill, P.J.; Moloney, A.J.; Ellis, I.O.; Hulman, G.; Jenkins, D.

Book ID
123398108
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
642 KB
Volume
30
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of promace-cytabom in p
A phase II trial of promace-cytabom in previously untreated non-hodgkin's lymphoma of intermediate- or high-grade histology
✍ G. Rossi; M. R. Mariano; G. Arcangeli; V. Bonfanti; M. A. Capucci; P. Ferremi; P πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 560 KB

the aggressive combination chemotherapy programme ProMACE-CytaBOM was used at a community-based hospital as primary treatment for non-Hodgkin's lymphoma (NHL) of intermediate or high-grade histology in Ann-Arbor stages IB-IV. The 53 patients entering the study represented 90 per cent of all consecut

A phase II study of a THP-COP regimen fo
A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma
✍ Hisashi Tsurumi; Takeshi Hara; Naoe Goto; Nobuhiro Kanemura; Senji Kasahara; Mic πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

## Abstract Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than doxorubicin. A phase II study was conducted in order to determine the efficacy of a treatment regimen incorporating THP, namely THP‐COP in the treatment of elderly